EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Disinfection Therapy for Atopic Dermatitis

International Journal of Clinical & Experimental Dermatology · 2016

DOI: 10.33140/ijced.01.01.06 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical & Experimental Dermatology, 2016. Die Arbeit nennt 76 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a susceptibility to infection in one of the pathogenesis of atopic dermatitis [1-4]. Kobayashi et al. Have reported that Staphylococcus aureus in the onset and exacerbation of atopic dermatitis is involved [5]. From more of the skin of moderate or atopic dermatitis Staphylococcus aureus has been detected 100%. Staphylococcus aureus produce toxins at a high frequency. The toxins produced by Staphylococcus aureus will act as a super antigen [6]. That is, unlike the produce toxin normal antigens, by acting on antigen-presenting cells, and induce the order of magnitude of cytokines. In atopic dermatitis, as a failure of organs other than the skin, there are reports that acknowledge the lesions of the intestinal tract and cervical spine [7,8].

Zitieren

APA

(2016). Evaluation of Disinfection Therapy for Atopic Dermatitis. International Journal of Clinical & Experimental Dermatology. https://doi.org/10.33140/ijced.01.01.06

Vancouver

Evaluation of Disinfection Therapy for Atopic Dermatitis. International Journal of Clinical & Experimental Dermatology. 2016. doi:10.33140/ijced.01.01.06

BibTeX
@article{euvimed2016,
  title = {Evaluation of Disinfection Therapy for Atopic Dermatitis},
  journal = {International Journal of Clinical & Experimental Dermatology},
  year = {2016},
  doi = {10.33140/ijced.01.01.06}
}
Kostenlos starten →